Felt like she was getting a sinus infection; Sinus pressure; Shortness of breath; she noticed that she lost her sense of taste and smell (could not taste coffee or toothpaste); She noticed that she lost her sense of taste and smell (could not taste coffee or toothpaste); Really really tired, Dog tired; Contracted COVID19 - testd positive for COVID-19 after getting both doses; Lack of drug effect; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Contracted COVID19 - testd positive for COVID-19 after getting both doses), DRUG INEFFECTIVE (Lack of drug effect), SINUSITIS (Felt like she was getting a sinus infection), PARANASAL SINUS DISCOMFORT (Sinus pressure) and DYSPNOEA (Shortness of breath) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cerebral palsy (Mild). Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), VITAMIN B COMPLEX, LINUM USITATISSIMUM SEED OIL (FLAX SEED OIL), GLUCOSAMINE and PROBIOTICS NOS for an unknown indication.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Sep-2021, the patient experienced FATIGUE (Really really tired, Dog tired). On 25-Sep-2021, the patient experienced COVID-19 (Contracted COVID19 - testd positive for COVID-19 after getting both doses) and DRUG INEFFECTIVE (Lack of drug effect). On 28-Sep-2021, the patient experienced ANOSMIA (She noticed that she lost her sense of taste and smell (could not taste coffee or toothpaste)). On an unknown date, the patient experienced SINUSITIS (Felt like she was getting a sinus infection), PARANASAL SINUS DISCOMFORT (Sinus pressure), DYSPNOEA (Shortness of breath) and AGEUSIA (she noticed that she lost her sense of taste and smell (could not taste coffee or toothpaste)). At the time of the report, COVID-19 (Contracted COVID19 - testd positive for COVID-19 after getting both doses), DRUG INEFFECTIVE (Lack of drug effect), SINUSITIS (Felt like she was getting a sinus infection), PARANASAL SINUS DISCOMFORT (Sinus pressure), DYSPNOEA (Shortness of breath), ANOSMIA (She noticed that she lost her sense of taste and smell (could not taste coffee or toothpaste)), AGEUSIA (she noticed that she lost her sense of taste and smell (could not taste coffee or toothpaste)) and FATIGUE (Really really tired, Dog tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Other concomitant medications included unspecified birth control medication.  No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 11-Oct-2021: Patient date of birth, additional events, vaccine information and concomitant drugs were added.; Sender's Comments: This case concerns a 41-year-old, female patient, with medical history of mild cerebral palsy, who experienced non-serious, unexpected, AESI events of Covid-19, anosmia and ageusia, and other non-serious events drug ineffective, fatigue, sinus disorder, paranasal sinus discomfort, and dyspnea. The events occurred  7 months after second dose of Moderna vaccine. The rechallenge is not applicable as a third dose is not expected. The patient's medical history of mild cerebral palsy may have increased her risk of getting infected wit h Covid-19.  The benefit-risk relationship of Moderna vaccine is not affected by this report.